- GlobeNewswire•10 days ago
LAWRENCEVILLE, N.J., Dec. 01, 2016-- Celsion Corporation today announced that the independent Data Safety Monitoring Board has completed its safety review of data from the first four patient cohorts in ...
- GlobeNewswire•11 days agoCelsion Announces Data Monitoring Committee Unanimously Recommends Continuation of Phase III OPTIMA Study of ThermoDox® for Primary Liver Cancer
LAWRENCEVILLE, N.J., Nov. 30, 2016-- Celsion Corporation today announced that following a review of data from its multinational, randomized pivotal Phase III clinical study of ThermoDox ® in combination ...
- GlobeNewswire•12 days agoCelsion Corporation Announces Presentation of Results from Independent NIH Analysis of ThermoDox® plus Optimized RFA for the Treatment of Primary Liver Cancer at the 2016 RSNA Annual Meeting
NIH Analysis of Data from Celsion’ s HEAT Study Reaffirms Correlation Between Increased RFA Burn Time per Tumor Volume and Significant Improvements in Overall Survival. Prior Subgroup Analysis of HEAT ...
CLSN : Summary for Celsion Corporation - Yahoo Finance
Celsion Corporation (CLSN)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
|Bid||0.60 x 1700|
|Ask||1.01 x 1700|
|Day's Range||0.64 - 0.68|
|52 Week Range||0.62 - 2.05|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-0.76|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|